When selecting samples for HLA gene determination in nasopharyngeal cancer patients, we randomized only 30 patients with nasopharyngeal cancer who met the nasopharyngeal cancer patient criteria, and we identified the presence of the LMP1-EBV gene in nasopharyngeal biopsy tissue samples to assess objective 1. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.